EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway
Nan Ding, A‐Bin You, Senxia Zhao, Hu Yang, Chun-Ping Lai, Feng Ye
Topics & Concepts
MedicineCancer researchEsophageal cancerPharmacologyCancerIn vivoInternal medicineBiologyBiotechnologyCancer-related gene regulationEpigenetics and DNA MethylationHistone Deacetylase Inhibitors Research